Clinical Evidence

Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Medium Cut-off Dialyzers in a Large Population of Hemodialysis Patients in Colombia: COREXH Registry
Visit resource site
HDx therapy enabled by Theranova
Medium Cut-Off Membrane Can Be a New Treatment Tool in Amanita phalloides Poisoning.
Visit resource site
HDx therapy enabled by Theranova
Medium cut-off membranes - closer to the natural kidney removal function
Visit resource site
HDx therapy enabled by Theranova
Medium Cut-Off Membranes: Incremental or Quantum Leap Innovation in Haemodialysis?
Visit resource site
HDx therapy enabled by Theranova
Medium Cut-Off versus Low-Flux Dialyzers in Hemodialysis Patients with COVID-19: Clinical Outcomes and Reduction in Interleukin-6
Visit resource site
HDx therapy enabled by Theranova
Medium Cutoff Versus High-Flux Hemodialysis Membranes and Clinical Outcomes: A Cohort Study Using Inverse Probability Treatment Weighting
Visit resource site
HDx therapy enabled by Theranova
Medium cut‑of dialyzer for middle molecular uremic toxins in AKI and chronic dialysis
Visit resource site
HDx therapy enabled by Theranova
Medium cut‑off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin‑independent manner in maintenance hemodialysis patients: results from a randomized controlled trial
Visit resource site
HDx therapy enabled by Theranova
Medium-cut off hemodialysis with theranova dialyzer as an alternative to hemodiafiltration: A prospective cohort study
Visit resource site
HDx therapy enabled by Theranova
Membrane Innovation in Dialysis - Boschetti-de-Fierro A et al.
Visit resource site
HDx therapy enabled by Theranova
Membrane innovation: closer to native kidneys - Storr M, Ward RA.
Visit resource site
HDx therapy enabled by Theranova
Middle cut off (MCO) dialyzers in patients with multiple myeloma - removal of light chains with HDx-therapy
Visit resource site

Vantive is a trademark of Vantive Health LLC or its affiliates.